Biotech Firm to Provide Alternatives to Vaccines Using Tissue From Abortions
by Steven Ertelt
LifeNews.com Editor
February 29, 2008

Seattle, WA (LifeNews.com) -- A biotech firm has announced it will offer ethical alternatives to some of the vaccines that currently rely on the use of fetal tissue from abortions. The Seattle-based AVM Biotechnology says it will produce ethical alternatives in the fields of biotechnology, pharmaceuticals, and vaccine development.

The news gives hope to pro-life people who have been reluctant to use some vaccines because their development came as a result of the destruction of unborn children. the rest